Home LiteratureArticle Details
PMID: 6447751 Published · ppublish English Journal Article

Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.

The Journal of experimental medicine ·Vol. 152 ·No. 3 ·1980-09-01 ·Pages 594-607

Howard JG, Hale C, Liew FY

Abstract

BALB/c mice have been an exceptional susceptibility to Leishmania tropica infection such that cutaneous lesions grow without restraint in all cases leading to fatal metastasis and visceralization in normal and x-irradiated, bone-marrow reconstituted (XBM) animals. Adult thymectomized, x-irradiated, bone marrow-reconstituted (ATxXBM) BALB/c mice, however, show pronounced retardation of lesion growth leading to some survival and even cures. A similar trend was also found in moderately susceptible (BALB/c X C57BL/6)F1 mice, in contrast with the "resistant" CBA strain, in which, as previously known, ATxXBM animals showed impairment of normal, spontaneous self-healing. These convere effects are paralleled by respective leishmania-specific delayed-type hypersensitivity (DTH) reactivities, prior thymectomy leading to diminution in CBA and augmentation in BALB/c and (BALB/c X C57BL/6)F1. Anti-leishmanial DTH responses, amplfiable by cyclophosphamide pretreatment, can be detected in BALB/c mice within 10 d of infection with 2 X 10(7) promastigotes, but becomes near-totally suppressed by day 25-35. No such suppressin is found in CBA, C57BL/6, or (BALB/c X C57BL/6)F1 mice together with varying degrees of immune control of lesion development or regression. Suppression of DTH in BALB/c mice is leishmania specific and does not extent to 2,4-dinitrofluorobenzene (DNFB) or sheep erythrocytes specificities. Spleen cells from suppressed L. tropica-infected mice when transferred to normal BALB/c mice impaired the induction of DTH to leishmanial antigen. This property resided in the T cell-enriched fraction and not in the T cell-depleted fraction. It is concluded that a major component of the striking inability of BALB/c mice to control L. tropica infection involves profound impairment of a potentially curative cell-mediated immune response by suppressor T cell generation. The possibility is discussed that this may be secondary to rapid amastigote (antigen) accumulation in macrophages expressing the primary genetic "defect."

MeSH Terms
Animals Cyclophosphamide/pharmacology Disease Models, Animal H-2 Antigens Hypersensitivity, Delayed/immunology Immune Tolerance/drug effects Immunity, Cellular/drug effects Leishmania/immunology Leishmaniasis/immunology Mice Spleen/immunology T-Lymphocytes, Regulatory/immunology Thymectomy
Chemicals
H-2 Antigens Cyclophosphamide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Howard J G
Hale C
Liew F Y
References (28)
28 references, click to expand
  1. Problems in leishmaniasis related to immunology.
    Curr Top Microbiol Immunol. 1969;48:29-42 PMID: 4187176
  2. Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis.
    Trans R Soc Trop Med Hyg. 1970;64(3):380-93 PMID: 4195254
  3. Immunity in cutaneous leishmaniasis of the guinea-pig.
    Clin Exp Immunol. 1970 Sep;7(3):301-41 PMID: 4249071
  4. The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig.
    J Pathol. 1971 Jul;104(3):153-65 PMID: 4108131
  5. Immunosuppression during trypanosomiasis.
    Br J Exp Pathol. 1972 Feb;53(1):40-3 PMID: 5014242
  6. Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.
    Clin Exp Immunol. 1972 Feb;10(2):337-57 PMID: 4558410
  7. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse.
    Ann Immunol (Paris). 1974 Mar-Apr;125(3):415-26 PMID: 4606666
  8. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
    J Exp Med. 1975 Mar 1;141(3):697-702 PMID: 1117258
  9. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Immunology. 1975 Dec;29(6):953-65 PMID: 325
  10. Model for disseminated cutaneous leishmaniasis.
    Science. 1975 Dec 19;190(4220):1198-200 PMID: 1198104
  11. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.
    Clin Exp Immunol. 1976 Jan;23(1):126-38 PMID: 1261086
  12. Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells.
    Eur J Immunol. 1976 Apr;6(4):296-301 PMID: 62667
  13. Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity.
    J Exp Med. 1977 Feb 1;145(2):237-48 PMID: 299878
  14. Suppressor cells in experimentally trypanosomiasis.
    Nature. 1977 Feb 10;265(5594):539-41 PMID: 299925
  15. Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity.
    Eur J Immunol. 1976 Oct;6(10):674-9 PMID: 1087845
  16. Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera.
    Cell Immunol. 1977 Jun 15;31(2):364-9 PMID: 301441
  17. Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei.
    Clin Exp Immunol. 1977 Jul;29(1):122-31 PMID: 302169
  18. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
    Eur J Immunol. 1977 Oct;7(10):714-8 PMID: 303999
  19. Dissociative effects of malarial infection on humoral and cell-mediated immunity in mice.
    Immunology. 1979 May;37(1):35-44 PMID: 381176
  20. Alterations of the immune response associated with chronic experimental leishmaniasis.
    Infect Immun. 1979 Jul;25(1):16-22 PMID: 157979
  21. Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice.
    J Clin Lab Immunol. 1978 Nov;1(3):207-19 PMID: 387961
  22. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
    J Exp Med. 1980 Jan 1;151(1):69-80 PMID: 6444236
  23. Major histocompatibility gene complex (MHC)-coded determinants on antigen-specific suppressor factor for delayed-type hypersensitivity and surface phenotypes of cells producing the factor.
    Eur J Immunol. 1980 Apr;10(4):305-9 PMID: 6156846
  24. STUDIES ON THE RECOVERY OF THE IMMUNE RESPONSE IN IRRADIATED MICE THYMECTOMIZED IN ADULT LIFE.
    J Exp Med. 1964 May 1;119:837-50 PMID: 14157033
  25. CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
    Ann Trop Med Parasitol. 1964 Dec;58:420-30 PMID: 14249021
  26. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.
    Clin Exp Immunol. 1977 Oct;30(1):130-40 PMID: 606434
  27. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
    Eur J Immunol. 1978 Mar;8(3):172-6 PMID: 306925
  28. Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice.
    J Exp Med. 1979 May 1;149(5):1018-28 PMID: 312893
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1980-09-01
Pages
594-607
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2185923
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com